How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

835 results for

Postpartum Office Visit

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

101. Perineal care

in its current form for non-commercial purposes, as long as you attribute Queensland Clinical Guidelines, Queensland Health and abide by the licence terms. You may not alter or adapt the work in any way. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/3.0/au/deed.en For further information, contact Queensland Clinical Guidelines, RBWH Post Office, Herston Qld 4029, email Guidelines@health.qld.gov.au, phone (07) 3131 6777. For permissions beyond the scope (...) of this licence, contact: Intellectual Property Officer, Queensland Health, GPO Box 48, Brisbane Qld 4001, email ip_officer@health.qld.gov.au, phone (07) 3234 1479. Queensland Clinical Guideline: Perineal care Refer to online version, destroy printed copies after use Page 3 of 39 Flow Chart: Antenatal and intrapartum perineal care Queensland Clinical Guidelines: F18.30-1-V3-R23 Antenatally: · Assess for risk factors · Offer information about: o Risk of perineal injury in vaginal birth o Antenatal

2018 Queensland Health

102. Sodium and Potassium Intake: Effects on Chronic Disease Outcomes and Risks

, and the health care system as a whole. Transparency and stakeholder input are essential to the Effective Health Care Program. Please visit the Web site (www.effectivehealthcare.ahrq.gov) to see draft research questions and reports or to join an email list to learn about new program products and opportunities for input. We welcome comments on this systematic review. They may be sent by mail to the Task Order Officer named below at: Agency for Healthcare Research and Quality, 5600 Fishers Lane, Rockville, MD (...) 20857, or by email to epc@ahrq.hhs.gov. Gopal Khanna, M.B.A. Director Agency for Healthcare Research and Quality Stephanie Chang M.D., M.P.H. Director Evidence-based Practice Center Program Center for Evidence and Practice Improvement Agency for Healthcare Research and Quality Arlene S. Bierman, M.D., M.S. Director Center for Evidence and Practice Improvement Agency for Healthcare Research and Quality David W. Niebuhr, M.D., M.P.H., M.Sc. Task Order Officer Center for Evidence and Practice

2018 Effective Health Care Program (AHRQ)

104. Unhealthy Alcohol Use in Adolescents and Adults: Screening and Behavioral Counseling Interventions

was 1 (range, 0-21). The median length of time of contact was 30 minutes (range, 1-600 minutes). Most of the interventions had a total contact time of 2 hours or less. Primary care settings often used the Screening, Brief Intervention, and Referral to Treatment (SBIRT) approach. Interventions targeting adults other than college students (including pregnant and postpartum women) were more likely to take place in primary care settings, have multiple sessions, and involve a primary care team. Most (...) in young adults, 27 in general adult populations, 1 in older adults, and 2 in pregnant or postpartum women. Twenty-eight studies were fair quality and 17 were good quality. Most studies took place in the United States (62%), and 51% of the studies recruited patients from primary care settings. Studies evaluated AUDIT, AUDIT-C, ASSIST, and a variety of 1- or 2-item screening tests for detecting the full spectrum of unhealthy alcohol use. Screening instruments addressed a variety of elements

2018 U.S. Preventive Services Task Force

105. Screening for Perinatal Depression

(includingscreeningforpostpartumdepressionandanxietywithavalidatedinstrument)duringthecomprehensive postpartum visit for each patient. If a patient is screened for depression and anxiety during pregnancy, additional screening should then occur during the comprehensive postpartum visit. There is evidence that screening alone can have clinical benefits, although initiation of treatment or referral to mental health care providers offers maximum benefit. Therefore, clinical staff in obstetrics and gynecology practices should be prepared to initiate medical therapy, refer (...) tool. It is rec- ommended that all obstetrician–gynecologists and other obstetric care providers complete a full assessment of mood and emotional well-being (including screening for postpartum depression and anxiety with a validated instrument) during the comprehensive postpartum visit for each patient. If a patient is screened for depression and anxiety during pregnancy, additional screening should then occur during the comprehensive postpartum visit. c Women with current depression or anxiety

2018 American College of Obstetricians and Gynecologists

106. WHO recommendations on home-based records for maternal, newborn and child health

the contributors involved. We gratefully acknowledge the funding support received from Japan International Cooperation Agency (JICA). The views of the funding body did not influence the content of this guideline.vi WHO recommendations on home-based records for maternal, newborn and child health Acronyms and abbreviations ANC antenatal care ANC4 antenatal care (four visits) APGAR appearance, pulse, grimace, activity and respiration score ARI acute respiratory infection CASP Critical Appraisal Skills Programme (...) WHO Department of Immunization, Vaccines and Biologicals JICA Japan International Cooperation Agency MCA WHO Department of Maternal, Newborn, Child and Adolescent Health MCH maternal and child health MD mean difference M&E monitoring and evaluation MNCH maternal, newborn and child health NHD WHO Department of Nutrition for Health and Development OHCHR United Nations Office of the High Commissioner for Human Rights OR odds ratio PICO population (P), intervention (I), comparator (C), outcome (O) PND

2018 World Health Organisation Guidelines

107. Management of Pregnancy

Postpartum visit B. Actions at Every Visit At every visit, assess: • Blood pressure • Body mass index (BMI) • Weight gain • Medication reconciliation • Need for consultation with advanced prenatal care provider (e.g., obstetrician or maternal-fetal medicine) for women at high risk for preterm delivery ( ) Recommendation 18 Note: Please see the below sections and . Standard of Pregnancy Care Routine Pregnancy Care C. Interventions by Weeks Gestation Intervention ? Screen for intimate partner violence (...) these guidelines does not guarantee coverage of civilian sector care. Additional information on current TRICARE benefits may be found at www.tricare.mil or by contacting your regional TRICARE Managed Care Support Contractor. Version 3.0 – 2018VA/DoD Clinical Practice Guideline for the Management of Pregnancy March 2018 Page 2 of 147 Prepared by: The Management of Pregnancy Work Group With support from: The Office of Quality, Safety and Value, VA, Washington, DC & Office of Evidence Based Practice, U.S. Army

2018 VA/DoD Clinical Practice Guidelines

108. BHIVA/BASHH guidelines on the use of HIV pre-exposure prophylaxis (PrEP)

College London Dan Clutterbuck Consultant HIV and Sexual Health, NHS Lothian, Monica Desai Consultant Epidemiologist, Public Health England Nigel Field Senior Lecturer, Consultant Clinical Epidemiologist, University College London Justin Harbottle Programme Officer, Terrence Higgins Trust, London Zahra Jamal Policy and Research Officer, NAZ, London Sheena McCormack Professor of Clinical Epidemiology, MRC Clinical Trials Unit at University College London Adrian Palfreeman Consultant HIV and Sexual (...) on the use of PrEP 20 4.1.3.4 Drug resistance In the iPrEx trial, FTC-related drug resistance developed in two participants who had unrecognised acute HIV infection at baseline [19]. These individuals had a negative antibody test before starting PrEP, but later tested positive. In the PROUD study, two of the three participants with a positive HIV test at enrolment or the 4-week visit had FTC-related drug resistance; no resistance was detected in participants who acquired HIV post-randomisation [2

2018 British Association for Sexual Health and HIV

109. BTS Guidelines for the outpatient management of pulmonary embolism

in terms of other healthcare utilisation (hospital readmissions, emergency depart- ment visits and OP visits to a doctor’s office within 90 days). The only difference between the groups was a higher number of home nursing visits for LMWH administration, as expected, ii6 Howard LSGE, et al. Thorax 2018;73:ii1–ii29. doi:10.1136/thoraxjnl-2018-211539 BTS guideline in those treated as OPs compared with the IP group (348 vs 105 visits). There are two other UK studies which have reported data on LOS. Davies (...) ) T Wilkinson (UK) B Mohkelesi (USA) P Wolters (USA) Statistical Editors A Douiri (UK) C Flach (UK) C Jackson (UK) S Stanojevic (USA) R Szczesniak (USA) B Wagner (USA) Y Wang (UK) Journal Club Editor P Murphy (UK) President, British Thoracic Society Professor M Woodhead Editorial Office Thorax, BMA House, Tavistock Square, London WC1H 9JR, UK T: +44 (0)20 7383 6373 E: thorax@bmj.com Twitter: @ThoraxBMJ ISSN: 0040-6376 (print) ISSN: 1468-3296 (online) Disclaimer: Thorax is owned and published

2018 British Thoracic Society

110. Prenatal and Perinatal Human Immunodeficiency Virus Testing - Expanded Recommendations

and reliable information, this publication is provided “as is” without any warranty of accuracy, reliability, or otherwise, either express or implied. ACOG does not guarantee, warrant, or endorse the products or services of any firm, organization, or person. Neither ACOG nor its officers, directors, members, employees, or agents will be liable for any loss, damage, or claim with respect to any liabilities, including direct, special, indirect, or consequential damages, incurred in connection (...) , arthralgias, headache, oral ulcers, leukopenia, thrombocytopenia, or transaminase elevation). Rapid screening during labor and delivery or during the immediate postpartum period using the opt-out approach should be done for women who were not tested earlier in pregnancy or whose HIV status is otherwise unknown. Results should be available 24 hours a day and within 1 hour. If a rapid HIV test result in labor is reactive, antiretroviral prophylaxis should be immediately initiated while waiting

2018 American College of Obstetricians and Gynecologists

111. Labor and Delivery Management of Women With Human Immunodeficiency Virus Infection

to this document can be found on or by calling the ACOG Resource Center. While ACOG makes every effort to present accurate and reliable information, this publication is provided “as is” without any warranty of accuracy, reliability, or otherwise, either express or implied. ACOG does not guarantee, warrant, or endorse the products or services of any firm, organization, or person. Neither ACOG nor its officers, directors, members, employees, or agents will be liable for any loss, damage, or claim with respect (...) at the initial prenatal visit, 2–4 weeks after initiating (or changing) cART drug regimens; monthly until RNA levels are undetectable; and then at least every 3 months during pregnancy. Pregnant women infected with HIV whose viral loads are more than 1,000 copies/mL at or near delivery, independent of antepartum antiretroviral therapy, or whose levels are unknown, should be counseled regarding the potential benefit of and offered scheduled prelabor cesarean delivery at 38 0/7 weeks of gestation to reduce

2018 American College of Obstetricians and Gynecologists

112. Cardiovascular Health in Turner Syndrome: A Scientific Statement From the American Heart Association

of age. The transition process in this patient population should address the cardiovascular risks, associated congenital heart defects if applicable, and topics such as the educational and psychosocial needs. These topics are introduced gradually and reinforced in subsequent clinic visits and communications. Preparing the adolescent with TS for self-care and independence in adulthood is the goal. Cardiovascular Health Care From Childhood to Adulthood In addition to the congenital heart defects (...) -driven care, regular medical visits, and a reduction in morbidity. Suggestions for Clinical Practice Lifelong cardiac follow-up is recommended for all individuals with TS, even in the absence of cardiovascular disease. Medical care during adulthood should be guided by a multidisciplinary team that includes a cardiologist with knowledge, experience, or a special interest in the unique cardiovascular issues facing women with TS. A heart-healthy lifestyle is essential and should be discussed

Full Text available with Trip Pro

2018 American Heart Association

113. Guideline supplement: Hypoxic-ischaemic encephalopathy

Non-Commercial No Derivatives 3.0 Australia licence. In essence, you are free to copy and communicate the work in its current form for non-commercial purposes, as long as you attribute Queensland Clinical Guidelines, Queensland Health and abide by the licence terms. You may not alter or adapt the work in any way. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/3.0/au/deed.en For further information contact Queensland Clinical Guidelines RBWH Post Office, Herston (...) Qld 4029, email Guidelines@health.qld.gov.au, phone (07) 3131 6777. For permissions beyond the scope of this licence contact: Intellectual Property Officer, Queensland Health, GPO Box 48, Brisbane Qld 4001, email ip_officer@health.qld.gov.au, phone (07) 3234 1479. Queensland Clinical Guideline Supplement: Hypoxic-ischaemic encephalopathy (HIE) Refer to online version, destroy printed copies after use Page 3 of 17 1 Introduction This document is a supplement to the Queensland Clinical Guideline

2018 Queensland Health

114. Induction of labour

current form for non-commercial purposes, as long as you attribute Queensland Clinical Guidelines, Queensland Health and abide by the licence terms. You may not alter or adapt the work in any way. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/3.0/au/deed.en For further information, contact Queensland Clinical Guidelines, RBWH Post Office, Herston Qld 4029, email Guidelines@health.qld.gov.au, phone (07) 3131 6777. For permissions beyond the scope of this licence (...) , contact: Intellectual Property Officer, Queensland Health, GPO Box 48, Brisbane Qld 4001, email ip_officer@health.qld.gov.au, phone (07) 3234 1479. Queensland Clinical Guideline: Induction of labour Refer to online version, destroy printed copies after use Page 3 of 30 Flow Chart: Method of induction of labour Flowchart: F17.22-1-V5-R22 Indication · Maternal and/or fetal benefit Contraindications · As for vaginal birth Communication with woman · Indication · Maternal &/or fetal benefit & risk

2018 Queensland Health

115. Using Clinical Laboratory Tests to Monitor Drug Therapy in Pain Management Patients

GA, MELANSON SE, AND LANGMAN LJ. AACC Academy Laboratory Medicine Practice Guideline:6 LABORATORY MEDICINE PRACTICE GUIDELINES cific. On the other hand, definitive or confirmatory testing (e.g. mass spectrometry- or chromatography-based) are able to iden- tify a specific drug and/or its associated metabolites. Outcomes included adherence, diversion, emergency de- partment visits, and others. The time period was from January 2000-February 2015 in outpatient, inpatient, and community settings (...) ) to classify prescription opioid analgesic abuse as an epidemic. This appears to be due in large part to individuals using a prescription drug non-medically, most often an opioid an- algesic. Drug-induced deaths have rapidly risen and continue to be one of the leading causes of death in Americans. In 2011, the Office of National Drug Control Policy established a multifaceted approach to address prescription drug abuse, including Prescrip- tion Drug Monitoring Programs (PDMPs) that allow practitioners

2018 American Academy of Pain Medicine

116. Guideline: counselling of women to improve breastfeeding practices

systematic and narrative reviews on the topic. A separate guidance document will expand on the details of a public health progamme on breastfeeding counselling. ACKNOWLEDGEMENTS This guideline was coordinated by the WHO Departments of Maternal, Newborn, Child and Adolescent Health and Nutrition for Health and Development. Dr Pura Rayco-Solon and Dr Nigel Rollins (in alphabetical order) oversaw the preparation of this document, as responsible technical officers. WHO acknowledges the technical guidance (...) ); at 1–2 weeks after birth (neonatal period); in the first 3–4 months (early infancy); at 6 months (at the start of complementary feeding); and after 6 months (late infancy and early childhood), with additional contacts as necessary (for instance, when planning to return to school or work, or any time that concerns or challenges related to breastfeeding arise) or when oppportunities for breastfeeding counselling occur (such as during child immunization visits).6 GUIDELINE: COUNSELLING OF WOMEN

2018 World Health Organisation Guidelines

117. Continuous glucose monitoring (CGM real-time) and flash glucose monitoring (FGM) as personal, standalone systems in patients with diabetes mellitus treated with insulin

, includes as follows: • Test for undiagnosed diabetes should be carried out at the first prenatal visit in those with risk factors, using standard diagnostic criteria. • Test for gestational diabetes mellitus should be carried out at 24–28 weeks of gestation in pregnant women not previously known to have diabetes. • Testing for persistent diabetes should be performed in women with gestational diabetes mellitus at 4-12 weeks postpartum, using the oral glucose tolerance test and clinically ap- propriate

2018 EUnetHTA

118. 2018 guidelines for the early management of patients with acute ischemic stroke

by the AHA Office of Science Operations. For more on AHA statements and guidelines development, visit . Select the “Guidelines & Statements” drop-down menu, then click “Publication Development.” Permissions: Multiple copies, modification, alteration, enhancement, and/or distribution of this document are not permitted without the express permission of the American Heart Association. Instructions for obtaining permission are located at . A link to the “Copyright Permissions Request Form” appears (...) contraindications such as coagulation abnormalities, recent surgery, or systemic bleeding do not coexist. Pregnancy IV alteplase administration may be considered in pregnancy when the anticipated benefits of treating moderate or severe stroke outweigh the anticipated increased risks of uterine bleeding. ( Class IIb; LOE C-LD ) The safety and efficacy of IV alteplase in the early postpartum period (<14 d after delivery) have not been well established. ( Class IIb; LOE C-LD ) Ophthalmological conditions Use of IV

2018 American Academy of Neurology

119. 2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association

. The expert peer review of AHA-commissioned documents (eg, scientific statements, clinical practice guidelines, systematic reviews) is conducted by the AHA Office of Science Operations. For more on AHA statements and guidelines development, visit . Select the “Guidelines & Statements” drop-down menu, then click “Publication Development.” Permissions: Multiple copies, modification, alteration, enhancement, and/or distribution of this document are not permitted without the express permission of the American (...) ) Patients with systemic malignancy and reasonable (>6 mo) life expectancy may benefit from IV alteplase if other contraindications such as coagulation abnormalities, recent surgery, or systemic bleeding do not coexist. Pregnancy IV alteplase administration may be considered in pregnancy when the anticipated benefits of treating moderate or severe stroke outweigh the anticipated increased risks of uterine bleeding. ( Class IIb; LOE C-LD ) The safety and efficacy of IV alteplase in the early postpartum

2018 American Heart Association

120. Clearing the Smoke on Cannabis: Maternal Cannabis Use during Pregnancy ? An Update

proposed changes to medical marijuana regulations. Retrieved from http://www.cfpc.ca/ uploadedFiles/Health_Policy/CFPC_Policy_Papers_ and_Endorsements/CFPC_Policy_Papers/Medical%20 Marijuana%20Position%20Statement%20CFPC.pdf Colorado Department of Public Health and Environment. (2017). Marijuana pregnancy and breastfeeding guidance for Colorado health care providers prenatal visits. Retrieved from https://www.colorado.gov/pacific/ sites/default/files/MJ_RMEP_Pregnancy-Breastfeeding- Clinical

2018 Canadian Centre on Substance Abuse

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>